Scientific Advisory Board

The Scientific Advisory Board (SAB) is comprised of experts in oncology, immunology, protein engineering, drug discovery and development. The SAB provides strategic and scientific counsel to Ichnos’ management and research and development team to help advance the company’s proprietary BEAT® platform and multispecifics directed at blood cancers and solid tumors.

Adam Cohen, M.D.

Associate Professor of Medicine, Director, Myeloma Immunotherapy, at the University of Pennsylvania, USA

View bio

Sergio Giralt, M.D.

Professor of Medicine, Deputy Division Head of Hematologic Malignancies at Memorial Sloan Kettering Cancer Center, USA

View bio

Philippe Moreau, M.D.

Professor of Clinical Hematology, Head of Translational Research at the University Hospital of Nantes, France

View bio

Stefan Dübel, Ph.D.

Biotechnology Professor and Department Director at the Technische Universität Braunschweig, Germany

View bio

Marion Subklewe, M.D.

Professor of Medicine, Head of Translational Cancer Immunology at Ludwig-Maximillans-Universitat, Germany

View bio

Lioudmila Tchistiakova, Ph.D.

Entrepreneur in Residence at Third Rock Ventures, Cambridge, Mass, USA

View bio

Lawrence Olanoff, M.D., Ph.D.

Director, Ichnos Sciences, Adjunct Assistant Professor and Special Advisor to the President for Corporate Relations at the Medical University of South Carolina, USA

View bio

Sonia Quaratino, M.D., Ph.D.

Director, Ichnos Sciences, Former Chief Medical Officer of Kymab

View bio

Wolf Herve Fridman, M.D., Ph.D.

Professor Emeritus of Immunology, at Université de Paris Medical School, France

View bio

View Career Opportunities

Career Opportunities

The link above is provided for your convenience, and Ichnos is not responsible for content, privacy, or security issues associated with your visit to external websites.